Trends in prevalence and outcome of heart failure with preserved ejection fraction

Author(s): Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al.

Abstract

Background:The prevalence of heart failure with preserved ejection fraction may be changing as a result of changes in population demographics and in the prevalence and treatment of risk factors for heart failure. Changes in the prevalence of heart failure with preserved ejection fraction may contribute to changes in the natural history of heart failure. We performed a study to define secular trends in the prevalence of heart failure with preserved ejection fraction among patients at a single institution over a 15-year period.

Methods:We studied all consecutive patients hospitalized with decompensated heart failure at Mayo Clinic Hospitals in Olmsted County, Minnesota, from 1987 through 2001. We classified patients as having either preserved or reduced ejection fraction. The patients were also classified as community patients (Olmsted County residents) or referral patients. Secular trends in the type of heart failure, associated cardiovascular disease, and survival were defined.

Results:A total of 6076 patients with heart failure were discharged over the 15-year period; data on ejection fraction were available for 4596 of these patients (76 percent). Of these, 53 percent had a reduced ejection fraction and 47 percent had a preserved ejection fraction. The proportion of patients with the diagnosis of heart failure with preserved ejection fraction increased over time and was significantly higher among community patients than among referral patients (55 percent vs. 45 percent). The prevalence rates of hypertension, atrial fibrillation, and diabetes among patients with heart failure increased significantly over time. Survival was slightly better among patients with preserved ejection fraction (adjusted hazard ratio for death, 0.96; P=0.01). Survival improved over time for those with reduced ejection fraction but not for those with preserved ejection fraction.

Conclusions:The prevalence of heart failure with preserved ejection fraction increased over a 15-year period, while the rate of death from this disorder remained unchanged. These trends underscore the importance of this growing public health problem.

Similar Articles

Omics meets hypothesisdriven research

Author(s): Ruegg C, Tissot JD, Farmer P, Mariotti A

Outcome of heart failure with preserved ejection fraction in a population-based study

Author(s): Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, et al.

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

Author(s): Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, et al.

Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction

Author(s): Gonzalez A, Lopez B, Querejeta R, Zubillaga E, Echeverria T, et al.

Inflammatory pathways in patients with heart failure and preserved ejection fraction

Author(s): Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, et al.

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

Author(s): Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, et al.

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

Author(s): Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, et al.

Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats

Author(s): Junhong W, Jing Y, Jizheng M, Shushu Z, Xiangjian C, et al.

Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness

Author(s): Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, et al.

Genome-wide association study identifies eight loci associated with blood pressure

Author(s): Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al.

Genome-wide association study of blood pressure and hypertension

Author(s): Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al.

Initial sequencing and analysis of the human genome

Author(s): Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al.

A second generation human haplotype map of over 3

Author(s): Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al.

Plasma cytokine parameters and mortality in patients with chronic heart failure

Author(s): Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al.

Colocalization of myocardial fibrosis and inflammatory cells in rats

Author(s): Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, et al.

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction

Author(s): Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, et al.

Sex-specific pathways in early cardiac response to pressure overload in mice

Author(s): Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs

Author(s): Kruger M, Kotter S, Grutzner A, Lang P, Andresen C, et al.

Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium

Author(s): Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, et al.

PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness

Author(s): Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, et al.

Role of extracellular matrix in vascular remodeling of hypertension

Author(s): riones AM, Arribas SM, Salaices M

Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old

Author(s): Mantero A, Gentile F, Gualtierotti C, Azzollini M, Barbier P, et al.

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

Author(s): Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, et al.

Sex Differences in Sympathetic Neural-Hemodynamic Balance: implications for human blood pressure regulation

Author(s): Hart EC, Charkoudian N, Wallin GG, Curry TB, Eisenach JH, et al.

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Author(s): Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al.